The Experts below are selected from a list of 612 Experts worldwide ranked by ideXlab platform
J Gordon Millichap - One of the best experts on this subject based on the ideXlab platform.
-
Lorenzo Oil Therapy for Adrenoleukodystrophy
Pediatric Neurology Briefs, 1993Co-Authors: J Gordon MillichapAbstract:Dietary therapy with glycerol trioleate and glycerol trierucate (Lorenzo Oil) was tested in 108 adult patients with adrenomyeloneuropathy phenotype of adrenoleukodystrophy (ALD) at Johns Hopkins Hospital and the Kennedy Krieger Institute, Baltimore, MD.
Hugo W. Moser - One of the best experts on this subject based on the ideXlab platform.
-
Visual evoked potentials in adrenolukodystrophy: A trial with glycerol trioleate and Lorenzo Oil
Annals of Neurology, 1993Co-Authors: Peter W. Kaplan, Ronald J. Tusa, Jan Shankroff, Joellen Heller, Hugo W. MoserAbstract:Adrenoleukodystrophy is an X-linked metabolic disorder with very-long-chain fatty acid (VLCFA) accumulation and multifocal nervous system demyelination, often with early involvement of visual pathways. Dietary therapy with glycerol trioleate and glycerol trierucate (Lorenzo Oil) diminishes VLCFA levels. In a study of patients with the adrenomyeloneuropathy phenotype of adrenoleukodystrophy, we used pattern-reversal visual evoked potentials to evaluate visual pathways before and after treatment. Of 108 patients tested, all 26 women and 68 of the 82 men had normal potentials at baseline. Seventy patients were retested at 1 year, at which time UCFA levels were markedly diminished
Peter W. Kaplan - One of the best experts on this subject based on the ideXlab platform.
-
Visual evoked potentials in adrenolukodystrophy: A trial with glycerol trioleate and Lorenzo Oil
Annals of Neurology, 1993Co-Authors: Peter W. Kaplan, Ronald J. Tusa, Jan Shankroff, Joellen Heller, Hugo W. MoserAbstract:Adrenoleukodystrophy is an X-linked metabolic disorder with very-long-chain fatty acid (VLCFA) accumulation and multifocal nervous system demyelination, often with early involvement of visual pathways. Dietary therapy with glycerol trioleate and glycerol trierucate (Lorenzo Oil) diminishes VLCFA levels. In a study of patients with the adrenomyeloneuropathy phenotype of adrenoleukodystrophy, we used pattern-reversal visual evoked potentials to evaluate visual pathways before and after treatment. Of 108 patients tested, all 26 women and 68 of the 82 men had normal potentials at baseline. Seventy patients were retested at 1 year, at which time UCFA levels were markedly diminished
Ronald J. Tusa - One of the best experts on this subject based on the ideXlab platform.
-
Visual evoked potentials in adrenolukodystrophy: A trial with glycerol trioleate and Lorenzo Oil
Annals of Neurology, 1993Co-Authors: Peter W. Kaplan, Ronald J. Tusa, Jan Shankroff, Joellen Heller, Hugo W. MoserAbstract:Adrenoleukodystrophy is an X-linked metabolic disorder with very-long-chain fatty acid (VLCFA) accumulation and multifocal nervous system demyelination, often with early involvement of visual pathways. Dietary therapy with glycerol trioleate and glycerol trierucate (Lorenzo Oil) diminishes VLCFA levels. In a study of patients with the adrenomyeloneuropathy phenotype of adrenoleukodystrophy, we used pattern-reversal visual evoked potentials to evaluate visual pathways before and after treatment. Of 108 patients tested, all 26 women and 68 of the 82 men had normal potentials at baseline. Seventy patients were retested at 1 year, at which time UCFA levels were markedly diminished
Jan Shankroff - One of the best experts on this subject based on the ideXlab platform.
-
Visual evoked potentials in adrenolukodystrophy: A trial with glycerol trioleate and Lorenzo Oil
Annals of Neurology, 1993Co-Authors: Peter W. Kaplan, Ronald J. Tusa, Jan Shankroff, Joellen Heller, Hugo W. MoserAbstract:Adrenoleukodystrophy is an X-linked metabolic disorder with very-long-chain fatty acid (VLCFA) accumulation and multifocal nervous system demyelination, often with early involvement of visual pathways. Dietary therapy with glycerol trioleate and glycerol trierucate (Lorenzo Oil) diminishes VLCFA levels. In a study of patients with the adrenomyeloneuropathy phenotype of adrenoleukodystrophy, we used pattern-reversal visual evoked potentials to evaluate visual pathways before and after treatment. Of 108 patients tested, all 26 women and 68 of the 82 men had normal potentials at baseline. Seventy patients were retested at 1 year, at which time UCFA levels were markedly diminished
